Bladder preservation in invasive locally confined bladder cancer

Oncology Research and Treatment

Volumn 19, Issue 4, 1996, Pages 296-301

  Jung, P ^a   Jakse, G ^a  

^a RWTH AACHEN UNIVERSITY   (Germany)

Author keywords

Bladder Cancer; Chemotherapy; Cystectomy; Organ preservation; Radiotherapy

Indexed keywords

ANTINEOPLASTIC AGENT; CISPLATIN; DOXORUBICIN; FLUOROURACIL; METHOTREXATE; VINBLASTINE;

BLADDER CANCER; CANCER INVASION; HUMAN; ORGAN PRESERVATION; REVIEW;

EID: 0029845214     PISSN: 22965270     EISSN: None     Source Type: Journal    
DOI: 10.1159/000218818     Document Type: Article

References (70)

1. Silverherg E, Boring CC, Squires TC: Cancer statistics, CA Cancer J Clin 1990;40:9-26.
2. Wynder EL, Goldsmith R: The epidemiology of bladder cancer, A second look, Cancer 1977;40: 1246-1258.
3. Clavel J, Cordier S, Boccon-Gibod L: Tobacco and bladder cancer in males: Increased risk for inhalers and smokers of black tobacco, Int J Cancer 1989; 44:605-612.
4. Rathcrt P, Melchior HJ, Lutzeycr W: Phenacctin: A carcinogen for the urinary tract, J Urol 1975:113: 653-658.
5. Kantor AF, Hartge P, Hoover RN, et al: Urinary tract infection and risk of bladder cancer, Am J Epidemiol 1984:119:510-516.
6. Reuter VE: Pathology of bladder cancer; Assessment of prognostic variables and response to therapy, J Urol 1990:114:1128-1136.
7. UICC: TNM Classification and Malignant Tumours: 4th ed, 2nd rev, Berlin, Springer, 1992, pp 154-156.
8. Thrasher J V, Crawford ED: Current management of invasive and metastatic transitional cell carcinoma of the bladder, J Urol 1993:149:957-972.
9. Lamm DL: Long-term results of intravesical therapy for superficial bladder cancer, Urol Clin North Am 1992:19:573-508.
10. Soloway MS: Introduction and overview of intravesical therapy of superficial bladder cancer, Urology 1988:31(suppl 3):5-12.
11. Witjes JA, van dcr Meijden A P, Witjes WP, Does-burg W, Schafsma HE, Debruyne FM: A randomised prospective study comparing intravesical instillations of mitomycin C, BCG-Tice, and BCC-RIVM in pTa, pTl tumors and primary carcinoma in situ of the urinary bladder, Dutch South-East Cooperative Urological Group, Eur J Cancer 1993:29A: 1672-1676.
12. Mostofi FK, Sobin LH, Torloni H: Histological Typing of Urinary Bladder, International Histological Classification of TUmours, No 10, Geneva, WHO, 1973.
13. Jakse G, Loidl W, Seeber G, Hofstädter F: T1G3 transitional carcinoma of the bladder: An unfavorable tumor? J Urol 1987:137:39-43.
14. Herr HW, Jakse G, Sheinfeid J: The T1 bladder tumor, Semin Urol 1990;8:254-261.
15. Stöckle M, Alken P, Engelmann U, Jacobi GH, Riedmüller H, Hohenfellner R: Radical cystectomy often too late? Eur Urol 1986:13:361-365.
16. Heney NM, Ahmed S, Flanagan MJ for the National Bladder Cancer Collaborative Group: Superficial bladder cancer: Progression and recurrence, J Urol 1983;130:1083-1086.
17. Dalesio O, Schulman CC, Sylvester R: Superficial bladder cancer: Progression and recurrence, J Urol 1983:130:1083-1086.
18. Kurth KH, Schroeder FH, Debruyne F for the EORTC Genitourinary Tract Cancer Cooperative Group: Long term follow up in superficial transitional cell carcinoma of the bladder: Prognostic factors for time to first recurrence, recurrence rate and survival, Prog Clin Biol Res 1989:303:481-490.
19. Gilbert HA, Logan JL, Kagan AR: The natural history of papillary transitional cell carcinoma of the bladder and its treatment in an unselected population on the basis of histologic grading J Urol 1978; 119:488-492.
20. Jordan AM, Weingarten J, Murphy WM: Transitional cell neoplasms of the bladder: Can biologic potential be predicted from histologic grading? Cancer 1987:60:2766-2774.
21. Pagano F, Bassi P, Galetti TP: Results of contemporary radical cystectomy for invasive bladder cancer: A clinicopathological study with an emphasis on the inadequacy of the tumor, nodes and mctastases classification, J Urol 1991;145:45-49.
22. Skinner DG, Lieskovsky G: Management of invasive and high grade bladder cancer; in Diagnosis and Management of Genitourinary Cancer, Philadelphia, Saunders, 1988, p 295.
23. Whitmore WF, Batata M A, Thoneim MA, Grabstald H, Unal A: Radical cystectomy with or without prior irradia.ion in the treatment of bladder cancer, J Urol 1988:139:299A.
24. Wishnow KI, Levinson AK, Johnson DE: Stage B (P2/3aN0) transitional cell carcinoma of the bladder highly curable by radical cystectomy, Urology 1992;39:1-9.
25. S Stöckle, et al: Personal commun.
26. Montie JE, Wood DP Jr.: The risk of radical cystectomy, Br J Urol 1989;63:483-486.
27. Frazier HA, Robertson JE, Paulson DF: Complications of radical cystectomy and urinary' diversion: A retrospective review of 675 cases in 2 decades, J Urol 1992:148:1401-1405.
28. Skinner DG, Crawford ED, Kaufman J: Complications of radical cystectomy for carcinoma of the bladder, J Urol 1980:123:640-643.
29. McDougal WS: Metabolic complications of urinary intestinal diversion, J Urol 1992:147:1199-1208.
30. Hayakawa M, Kinoshita H, Murai M, Kumora S, Tazaki H: Early and late complications in 130 cases with ileal conduit diversion (in Japanese), Jpn J Urol 1979:11:1278-1286.
31. Wolf JS, Stoller MC: Management of upper tract calculi in patients with tubularized urinary diversions, J Urol 1991:145:266-269.
32. Jakse G, Appingcr P, Leyh H, Altwein JE, Hartung R: Sexualstorungen bei Blasenkarzinom-Patientinnen nach Zysteklomie, Aktucllc Urol 1990 21:64-68.
33. Koraitim M, Khalil R: Preservation of urosexual functions after radical cystectomy, Urology 1992:39: 117-121.
34. Romic R, Sjodin JG: Sexual function in men after radical cystectomy with or without urethrcctomy, ScandJ Urol Nephrol 1992;26:127-129.
35. Herr HW: Conservative management of muscle infiltrating bladder cancer: Prospective experience, J Urol 1986:136:256-261.
36. Henry K, Miller J, Mori M, Loening S, Fallon B: Comparison of transurethral resection to radical therapies for stage B bladder tumors, J Urol 1988: 140:964-970.
37. Solsona E, Iborra I, Ricos JV, Monros JL, Dumont R: Feasibility of transurethral resection for muscle infiltration carcinoma of the bladder: Prospective study, J Urol 1992;147:1513-1555.
38. Cummings KB, Mason JT, Correa RJ, Gibbons RP: Segmental resection in the management of bladder carcinoma, J Urol 1978;119:56-61.
39. Utz, DC, Schmitz SE, Fugelso PD, Farrow GM: Aclin-ico-pathologic evaluation of partial cystectomy for carcinoma of the urinary bladder, Cancer 1973:32: 1075-1081.
40. Lindahl F, Jorgensen D, Egvad K: Partial cystectomy for transitional cell carcinoma of the bladder, Scand J Urol Nephrol 1984:18:125-131.
41. Novik AC, Stewart BH: Partial cystectomy in the treatment of primary' and secondary carcinoma of the bladder, J Urol 1976:116:570-575.
42. Sweeney P, Jursh F.D, Resnick MI: Partial cystectomy, Urol Clin North Am 1992;19:1701-1711.
43. Bloom HJG, Hendry WF, Wallace DM, Skcct RC.: Treatment of T3 bladder cancer: Controlled trial of pre-operative radiotherapy and radical cystectomy versus radical radiotherapy, Br J Urol 1982:54: 136-141.
44. Sell A, Jakobson A, Nerstrom B, Sorensen BL, Steven K, Barlebo H: Treatment of advanced bladder cancer category T2, T3 and T4a, Scand J Urol Nephrol 1991;138(suppl):193-201.
45. Hope-Stone HF, Blandy JP, Oliver RTD, England H: Radical radiotherapy and salvage cystectomy in the treatment of invasive carcinoma of the bladder; in Oliver TRD, Hendry WF, Bloom HJG (eds): Bladder Cancer: Principles of Combination Therapy, London, Butterworth, 1989, pp 27-42.
46. Gospodarowicz MK, Hawkins MV, Rawlings GA, et al: Radical radiotherapy for muscle invasive transitional cell carcinoma of the bladder: Failure analysis, J Urol 1989:142:1448-1454.
47. Quilty PM, Duncan W: Primary radical radiotherapy for T3 transitional cell carcinoma of the bladder: An analysis of survival and control, Int J Radiat Oncol Biol Phys 1986;12:853-861.
48. Richards B, Bastable JR, Freedman L, Glashan RW, Newling DWN, Robinson MRG, Smith PH: Adjuvant chemotherapy with doxorubicin (adriamycin) and 5-fluorouracil in T3, NX, MO bladder cancer treated with radiotherapy, Br Urol 1983;55:386-391.
49. Scher HI: Should single agents be standard therapy for urothelial tumors? J Clin Oncol 1989:10: 694-697.
50. Lochrer PJ, Einhom LH, Elson PJ, et al: A randomized comparison of cisplatin alone or in combination with methotrexate, vinblastine, and doxorubicin in patients with metastatic urothelial carcinoma: A cooperative group study, J Clin Oncol 1992:10: 1066-1073.
51. Sternberg CN, Yagoda A, Scher HI, Herr HH: M-VAC for advanced transitional cell carcinoma of the urothelium, Efficacy and patterns of response, Cancer 1989:64:2448-2458.
52. Herr HW: 'The role of surgery in initial staging and follow-up; in Splinter TAW, Scher HI (eds): Neoadjuvant Chemotherapy in Invasive Bladder Cancer, Progress in Clinical and Biological Research, New York, Wiley Liss, 1990, vol 353, pp 35-43.
53. Splinter TWA, Pavone-Macaluso M, Jaqumin D, Roberts JT, Carpenticr P, DePauw M; Sylvester R: A EORTC-Gcnitourinary Group phase 2 study of chemotherapy in stage T34N0-xMO transitional cell cancer of the bladder, Evaluation of clinical response, J Urol 1992:148:1793-1796.
54. Pellegrini A: Neoadjuvant treatment for locally advanced bladder cancer: A randomized clinical trial, Proc 4th Int Symp on Advances in Urological Oncology, 1993, p48.
55. Hall RR: Personal cominun.
56. Jakse G: Personal commun.
57. Keating J, Zincke H, Morgan WR, Wood JR: Extended experience with neoadjuvant M-VAC chemotherapy for invasive transitional cell carcinoma of the urinary bladder, J Urol 1989:141:244a.
58. Kurth KH, Splinter TA, Jacqmin D, Members of the EORTC GU: Transitional cell carcinoma of the bladder: A phase II study of chemotherapy in T34 NO M0 of the EORTC GU group: in Alderson AR, Oliver RT, Hanham IV, Bloom HJ (eds): Urological Oncology, Dilemmas and Developments: New York, Wiley/Liss, 1991, vol 1, pp 115-128.
59. Soquet Y Surgery and adjuvant chemotherapy with high-dose methotrexate and folinic a acid rescue for infiltrating tumors of the bladder, Cancer Treat Rep 1981;65(suppl 1):187-189.
60. Herr HW, Scher HI: Neoadjuvant chemotherapy in partial cystectomy for invasive bladder cancer; in Lepor H, Uiwson RK (eds): Therapy for Genitourinary Cancer, New York, Kluwer Academic Publ, 1992, pp 99-103.
61. Gospodarowicz MK, Quilty PM, Scallict P, Tsujii H, Fossa SD, Horcnblas S, lsaka S, Prout GR, Shipley WU, Wijnmaalen AJ, Crawford ED, Jones WG, Kawai T:The place of radiation therapy as definitive treatment of bladder cancer, Int J Urol 1995:2 (suppl 2)41-48.
62. Jakse G, Frommhold II, zur Ncdden D: Combined radiation and themotherapy for locally advanced transitional cell carcinoma of the urinary bladder, Cancer 1985:55:1659-1664.
63. Shipley WU, Prout GR, Einstein AB, Rose MA: Treatment of invasive bladder cancer by cisplatin and radiation in patients unsuited for surgery', JAMA 1987:258:931-935.
64. Rotman M, Macchia R, Silvcrstein R: Treatment of advanced bladder cancer with irradiation and concomitant 5-fluorouracil infusion, Cancer 1987:59: 710-714.
65. Jakse G, Fritsch E, Frommhold H, Concurrent adriamycin and radiotherapy in locally advanced bladder cancer, Brit J Urol 1989;63:64-67.
66. Wallace DMA, Raghavan D, Kelly KA, Sandemann TF, Conn IG, Teriana N, Dunn J, Boulas J, Latief T: Neoadjuvant (pre-emptive) Cisplatin therapy in invasive transitional cell carcinoma of the bladder, Br J Urol 1991;67:608-615.
67. Coppin C, Gospodarowicz MK, Dixon P, Fair WR, Wilson BC: Improved local control of invasive bladder cancer concurrent cisplatin and preoperative or radical radiation (abstr), Proc Am Soc Clin Oncol 1992:11:198.
68. Sauer R, Dunst J, Altendorf-Hofmann A, Fischer H, Bornhof G Schritt KM: Radiotherapy with and without cisplatin bladder cancer, Int J Radiat Oncol Biol Phys 1990:19:687-691.
69. Kaufman DS, Shipley WU, Griffin PP, Heney NM, Alt hausen AF, Efird JT: Selective bladder preservation by combination treatment of invasive bladder cancer, N Engl J Med 1993:329-1377-1382.
70. Vale JA Liu K, Whitfield HN, Trott KR: Post-irradiation bladder dysfunction: Muscle strip findings, Urol Res 1994;22:51-55.